NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/31/2024
Back to search
Official data from USPTO
LASANTH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LASANTH
ST13
US500000090236132Class
35, 42, 45
Filing
90236132
Registration
7634013
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
12/31/2024
Trademark type
Word
Nice classes
35, 42, 45
Filing date
10/05/2020
Registration date
12/31/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/31/2024
Last transaction
12/31/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2023-10-00
First use in commerce
2023-10-00
Drawing code
4
Owner type
16
Owner location
Whitehouse Station, NJ
Examiner
ALBANO, ASHLEY
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Canopy Biopharma LLC
Representatives
Brian J. Focarino COOLEY LLP
Technical classification
Nice Classes
Class 35Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting services in the field of regulatory compliance; business development services; business strategy development services; business consulting and management in the field of clinical trialsregulatory submission management on behalf of medicalpharmaceuticalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; regulatory submission managementassisting others in preparing applications for medical technologiesmedicationspharmaceuticalbiopharmaceuticalsbiotechnology with governmental regulatory bodies around the world; regulatory submission managementproviding simultaneous multiple country submissions of applications for the registration and approval of medical technologiesmedicationspharmaceuticalbiopharmaceuticalsbiotechnology; providing information online regarding regulatory submission management; business management consultingstrategic planning and business advisory services provided to medicalmedical technologypharmaceuticalbiopharmaceuticalbiotechnology companiesgovernment agencieseducational and research institutionsin the fields of biologics and pharmaceuticals; providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for drug approval; regulatory submission managementassisting others in preparing applications for new drugs with governmental regulatory bodies; business consulting services in the field of biologics and pharmaceuticals
Class 42
Product research and development for others in the fields of biologics and pharmaceuticals; quality management servicesquality evaluation and analysisquality assurance and quality control in the field of biologics and pharmaceuticals; scientific consulting and research services relating to the field of pharmaceuticals and life sciencesbiologymedicine; consulting services in the fields of biotechnology and pharmaceuticalsdesigndevelopmenttechnical verification and technical validation of manufacturing and filling processesdrug formulationstesting protocols and analytical methods; scientific and technological servicesscientific researchanalysistestingrelated scientific studies in the field of chemistry and molecular biologybiologics and protein detectioncharacterizationanalysis and testing
Class 45
Regulatory compliance consulting servicesreviewing standards and practices to assist clients with compliance with governmental lawsregulations and rules in the fields of medical technologiesmedicationsbiopharmaceuticalsbiotechnology; providing technical regulatory affair consulting services directed to medicalmedical technologybiopharmaceuticalbiotechnology companies in order to assure compliance with food and drug administration's laws and regulations; provision of information online pertaining to regulatory compliance in the fields of medical technologiesmedicationsbiopharmaceuticalsbiotechnology; and regulatory compliance consulting in the fields of biologics and pharmaceuticals
Publications
History of USPTO decisions and trademark events.
47 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/31/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/06/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/06/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/05/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/05/2024
ALIE
ASSIGNED TO LIE
11/05/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/12/2024
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/17/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/17/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/17/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/17/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/29/2024
GNRT
NON-FINAL ACTION E-MAILED
05/29/2024
CNRT
SU - NON-FINAL ACTION - WRITTEN
05/29/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/30/2024
IUAF
USE AMENDMENT FILED
04/26/2024
EISU
TEAS STATEMENT OF USE RECEIVED
04/26/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/05/2023
EX5G
SOU EXTENSION 5 GRANTED
10/04/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/03/2023
EXT5
SOU EXTENSION 5 FILED
09/26/2023
EEXT
SOU TEAS EXTENSION RECEIVED
09/26/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/25/2023
EX4G
SOU EXTENSION 4 GRANTED
04/23/2023
EXT4
SOU EXTENSION 4 FILED
04/23/2023
EEXT
SOU TEAS EXTENSION RECEIVED
04/23/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/21/2022
EX3G
SOU EXTENSION 3 GRANTED
10/19/2022
EXT3
SOU EXTENSION 3 FILED
10/19/2022
EEXT
SOU TEAS EXTENSION RECEIVED
10/19/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/21/2022
EX2G
SOU EXTENSION 2 GRANTED
05/19/2022
EXT2
SOU EXTENSION 2 FILED
05/19/2022
EEXT
SOU TEAS EXTENSION RECEIVED
05/19/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/29/2021
EX1G
SOU EXTENSION 1 GRANTED
09/27/2021
EXT1
SOU EXTENSION 1 FILED
09/27/2021
EEXT
SOU TEAS EXTENSION RECEIVED
09/27/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/01/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/06/2021
PUBO
PUBLISHED FOR OPPOSITION
04/06/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/17/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/02/2021
DOCK
ASSIGNED TO EXAMINER
03/02/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/19/2020
NWAP
NEW APPLICATION ENTERED
10/08/2020
Continuous trademark protection
Get notified about every new filing that threatens LASANTH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.